[Form 4] Eli Lilly & Co. Insider Trading Activity
Jamere Jackson, identified as a Director of Eli Lilly & Co. (LLY), reported an acquisition of 200 shares of the company鈥檚 common stock on 08/08/2025 at a reported price of $639.563 per share. The Form 4 shows his ownership following the transaction as 9,401.724 shares, held directly.
Jamere Jackson, identificato come Direttore di Eli Lilly & Co. (LLY), ha segnalato l'acquisto di 200 azioni del capitale sociale della societ脿 il 08/08/2025 al prezzo riportato di $639.563 per azione. Il Modulo 4 mostra la sua detenzione dopo la transazione pari a 9,401.724 azioni, detenute direttamente.
Jamere Jackson, identificado como Director de Eli Lilly & Co. (LLY), inform贸 la adquisici贸n de 200 acciones del capital social de la compa帽铆a el 08/08/2025 a un precio informado de $639.563 por acci贸n. El Formulario 4 muestra su participaci贸n tras la operaci贸n en 9,401.724 acciones, en propiedad directa.
Jamere Jackson電� Eli Lilly & Co. (LLY)鞚� 鞚挫偓搿� 頇曥澑霅橃棃鞙茧┌, 08/08/2025鞐� 須岇偓 氤错喌欤� 200欤茧ゼ 欤茧嫻 $639.563鞐� 旆摑頄堧嫟瓿� 鞁犼碃頄堨姷雼堧嫟. Form 4鞐愲姅 瓯半灅 頉� 攴胳潣 氤挫湢臧� 9,401.724欤茧, 歆侅为 氤挫湢頃� 瓴冹溂搿� 旮办灛霅橃柎 鞛堨姷雼堧嫟.
Jamere Jackson, identifi茅 comme Directeur d'Eli Lilly & Co. (LLY), a d茅clar茅 avoir acquis 200 actions ordinaires de la soci茅t茅 le 08/08/2025 au prix d茅clar茅 de $639.563 par action. Le formulaire 4 indique sa d茅tention apr猫s la transaction 脿 9,401.724 actions, d茅tenues directement.
Jamere Jackson, ausgewiesen als Direktor von Eli Lilly & Co. (LLY), meldete den Erwerb von 200 Aktien der Stammaktien des Unternehmens am 08/08/2025 zu einem gemeldeten Preis von $639.563 je Aktie. Das Formular 4 weist seinen Bestand nach der Transaktion mit 9,401.724 Aktien aus, die direkt gehalten werden.
- None.
- None.
Insights
TL;DR: Small insider purchase; immaterial to valuation but indicates personal investment by a board member.
The Form 4 records a straightforward purchase of 200 shares at $639.563 per share, with the transaction coded as P. Relative to Eli Lilly鈥檚 market capitalization, this purchase is too small to move valuation or signal a material change in insider positions. It does, however, reflect a director adding to a direct holding of 9,401.724 shares, a routine disclosure that investors monitor for alignment.
TL;DR: A modest director buy that marginally increases insider alignment but is not material on its own.
The filing lists Jamere Jackson as a Director and reports a purchase that increases his direct beneficial ownership to 9,401.724 shares. While insider purchases can signal confidence, the size here is small versus company scale. The form is properly signed by an authorized designee, indicating standard compliance with Section 16 reporting.
Jamere Jackson, identificato come Direttore di Eli Lilly & Co. (LLY), ha segnalato l'acquisto di 200 azioni del capitale sociale della societ脿 il 08/08/2025 al prezzo riportato di $639.563 per azione. Il Modulo 4 mostra la sua detenzione dopo la transazione pari a 9,401.724 azioni, detenute direttamente.
Jamere Jackson, identificado como Director de Eli Lilly & Co. (LLY), inform贸 la adquisici贸n de 200 acciones del capital social de la compa帽铆a el 08/08/2025 a un precio informado de $639.563 por acci贸n. El Formulario 4 muestra su participaci贸n tras la operaci贸n en 9,401.724 acciones, en propiedad directa.
Jamere Jackson電� Eli Lilly & Co. (LLY)鞚� 鞚挫偓搿� 頇曥澑霅橃棃鞙茧┌, 08/08/2025鞐� 須岇偓 氤错喌欤� 200欤茧ゼ 欤茧嫻 $639.563鞐� 旆摑頄堧嫟瓿� 鞁犼碃頄堨姷雼堧嫟. Form 4鞐愲姅 瓯半灅 頉� 攴胳潣 氤挫湢臧� 9,401.724欤茧, 歆侅为 氤挫湢頃� 瓴冹溂搿� 旮办灛霅橃柎 鞛堨姷雼堧嫟.
Jamere Jackson, identifi茅 comme Directeur d'Eli Lilly & Co. (LLY), a d茅clar茅 avoir acquis 200 actions ordinaires de la soci茅t茅 le 08/08/2025 au prix d茅clar茅 de $639.563 par action. Le formulaire 4 indique sa d茅tention apr猫s la transaction 脿 9,401.724 actions, d茅tenues directement.
Jamere Jackson, ausgewiesen als Direktor von Eli Lilly & Co. (LLY), meldete den Erwerb von 200 Aktien der Stammaktien des Unternehmens am 08/08/2025 zu einem gemeldeten Preis von $639.563 je Aktie. Das Formular 4 weist seinen Bestand nach der Transaktion mit 9,401.724 Aktien aus, die direkt gehalten werden.
FAQ
What did Jamere Jackson report on the Form 4 for LLY?
What is Jamere Jackson's role at Eli Lilly?
How many shares does Jamere Jackson own after the reported transaction?
What transaction code is shown on the Form 4?
Who signed the Form 4 on behalf of the reporting person?
